a public good project by the
Synthesis
Company
of California

© 2026

Kai Mo | doi.page

0 works0 citations0 h-index

Kai Mo

Zhujiang Hospital(CN)First Affiliated Hospital of GuangXi Medical University(CN)First People's Hospital of Nanning(CN)Sichuan Research Center of New Materials(CN)Southern Medical University(CN)

Publications by Year

Research Areas

Pain Mechanisms and Treatments, Nerve injury and regeneration, Cancer-related gene regulation, Hereditary Neurological Disorders, Advancements in Battery Materials

Most-Cited Works

→ DNA methyltransferase DNMT3a contributes to neuropathic pain by repressing Kcna2 in primary afferent neurons(2017)227 cited
→ Contribution of DNMT1 to Neuropathic Pain Genesis Partially through Epigenetically Repressing Kcna2 in Primary Afferent Neurons(2019)105 cited
→ DNMT3a‐triggered downregulation of K_2p1.1 gene in primary sensory neurons contributes to paclitaxel‐induced neuropathic pain(2019)102 cited
→ Nerve injury–induced epigenetic silencing of opioid receptors controlled by DNMT3a in primary afferent neurons(2017)95 cited
→ Dorsal root ganglion transcriptome analysis following peripheral nerve injury in mice(2016)93 cited
→ G9a participates in nerve injury-induced Kcna2 downregulation in primary sensory neurons(2016)89 cited

→ N6‐Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons(2020)89 cited

→ The transcription factor C/EBPβ in the dorsal root ganglion contributes to peripheral nerve trauma–induced nociceptive hypersensitivity(2017)68 cited

→ G9a inhibits CREB-triggered expression of mu opioid receptor in primary sensory neurons following peripheral nerve injury(2016)58 cited

→ MBD1 Contributes to the Genesis of Acute Pain and Neuropathic Pain by Epigenetic Silencing ofOprm1andKcna2Genes in Primary Sensory Neurons(2018)56 cited